Boston Scientific (NYSE:BSX) is warning healthcare providers that patients implanted with certain of its older Emblem S-ICD cardioverter defibrillators may need early revision surgery due to premature battery depletion.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,